These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 16641323

  • 1. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures.
    Glauser TA, Ayala R, Elterman RD, Mitchell WG, Van Orman CB, Gauer LJ, Lu Z, N159 Study Group.
    Neurology; 2006 Jun 13; 66(11):1654-60. PubMed ID: 16641323
    [Abstract] [Full Text] [Related]

  • 2. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J, Coetzee C, Jiménez F, Litovchenko T, Ramaratnam S, Zaslavaskiy L, Lu ZS, Sykes DM, Levetiracetam XR N01235 Study Group.
    Epilepsia; 2009 Mar 13; 50(3):406-14. PubMed ID: 19317886
    [Abstract] [Full Text] [Related]

  • 3. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY, Hong Z, Wu X, Wu LW, Wang XF, Zhou D, Zhao ZX, Lv CZ.
    Epilepsia; 2009 Mar 13; 50(3):398-405. PubMed ID: 18657175
    [Abstract] [Full Text] [Related]

  • 4. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
    Piña-Garza JE, Nordli DR, Rating D, Yang H, Schiemann-Delgado J, Duncan B, Levetiracetam N01009 Study Group.
    Epilepsia; 2009 May 13; 50(5):1141-9. PubMed ID: 19243423
    [Abstract] [Full Text] [Related]

  • 5. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM, Mintz M, Hunter SJ, Yang H, Jones J, N01103 Levetiracetam Study Group.
    Epilepsia; 2009 Nov 13; 50(11):2377-89. PubMed ID: 19702752
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures.
    Xiao Z, Li JM, Wang XF, Xiao F, Xi ZQ, Lv Y, Sun HB.
    Eur Neurol; 2009 Nov 13; 61(4):233-9. PubMed ID: 19176965
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG, Berkovic SF, Black AB, Danta G, Hiersemenzel R, Schapel GJ, Vajda FJ.
    Epilepsy Res; 2005 Jan 13; 63(1):1-9. PubMed ID: 15716083
    [Abstract] [Full Text] [Related]

  • 8. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ, Somerville ER, Van Paesschen W, Ryvlin P, Schelstraete I.
    Epilepsy Res; 2007 Aug 13; 76(1):6-14. PubMed ID: 17681453
    [Abstract] [Full Text] [Related]

  • 9. Levetiracetam extended release and levetiracetam immediate release as adjunctive treatment for partial-onset seizures: an indirect comparison of treatment-emergent adverse events using meta-analytic techniques.
    Richy FF, Banerjee S, Brabant Y, Helmers S.
    Epilepsy Behav; 2009 Oct 13; 16(2):240-5. PubMed ID: 19699156
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of levetiracetam: a review of three pivotal clinical trials.
    Privitera M.
    Epilepsia; 2001 Oct 13; 42 Suppl 4():31-5. PubMed ID: 11564123
    [Abstract] [Full Text] [Related]

  • 11. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA).
    Stefan H, Wang-Tilz Y, Pauli E, Dennhöfer S, Genow A, Kerling F, Lorber B, Fraunberger B, Halboni P, Koebnick C, Gefeller O, Tilz C.
    Epilepsia; 2006 Mar 13; 47(3):516-22. PubMed ID: 16529615
    [Abstract] [Full Text] [Related]

  • 12. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
    Brodie MJ, Duncan R, Vespignani H, Solyom A, Bitenskyy V, Lucas C.
    Epilepsia; 2005 Jan 13; 46(1):31-41. PubMed ID: 15660766
    [Abstract] [Full Text] [Related]

  • 13. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
    Fountain NB, Conry JA, Rodríguez-Leyva I, Gutierrez-Moctezuma J, Salas E, Coupez R, Stockis A, Lu ZS.
    Epilepsy Res; 2007 Apr 13; 74(1):60-9. PubMed ID: 17270398
    [Abstract] [Full Text] [Related]

  • 14. Adjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: subpopulation analysis of a prospective, open-label extension study of up to 48 weeks.
    Piña-Garza JE, Schiemann-Delgado J, Yang H, Duncan B, Hadac J, Hunter SJ.
    Clin Ther; 2010 Oct 13; 32(11):1935-50. PubMed ID: 21095488
    [Abstract] [Full Text] [Related]

  • 15. Levetiracetam monotherapy in children with epilepsy.
    Khurana DS, Kothare SV, Valencia I, Melvin JJ, Legido A.
    Pediatr Neurol; 2007 Apr 13; 36(4):227-30. PubMed ID: 17437904
    [Abstract] [Full Text] [Related]

  • 16. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.
    Halász P, Kälviäinen R, Mazurkiewicz-Beldzińska M, Rosenow F, Doty P, Hebert D, Sullivan T, SP755 Study Group.
    Epilepsia; 2009 Mar 13; 50(3):443-53. PubMed ID: 19183227
    [Abstract] [Full Text] [Related]

  • 17. Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial.
    Brodie MJ, Rosenfeld WE, Vazquez B, Sachdeo R, Perdomo C, Mann A, Arroyo S.
    Epilepsia; 2009 Aug 13; 50(8):1899-909. PubMed ID: 19490053
    [Abstract] [Full Text] [Related]

  • 18. Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures.
    Elger C, Bialer M, Cramer JA, Maia J, Almeida L, Soares-da-Silva P.
    Epilepsia; 2007 Mar 13; 48(3):497-504. PubMed ID: 17319919
    [Abstract] [Full Text] [Related]

  • 19. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
    Uthman BM, Almas M, Emir B, Giordano S, Leon T.
    Curr Med Res Opin; 2011 Jul 13; 27(7):1285-93. PubMed ID: 21561392
    [Abstract] [Full Text] [Related]

  • 20. Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizures.
    Faught E, Holmes GL, Rosenfeld WE, Novak G, Neto W, Greenspan A, Schmitt J, Yuen E, Reines S, Haas M.
    Neurology; 2008 Nov 11; 71(20):1586-93. PubMed ID: 19001248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.